Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Apr 22 424B3 Prospectus supplement
- 28 Apr 22 EFFECT Notice of effectiveness
-
11 Apr 22 S-3 Shelf registration
VCNX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 31, 2022, relating to the financial statements of Vaccinex, Inc. (the “Company”), appearing in the Annual Report on Form 10-K of the Company filed on March 31, 2022, for the year ended December 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte & Touche LLP
Williamsville, New York
April 11, 2022